Acute ischemic stroke (AIS) management has evolved significantly during the past 20 years, with the development of stroke units and advances in reperfusion therapies. Until recently, reperfusion mainly consisted of intravenous thrombolysis (IVT), which has proven efficacy when administered within 4.5 hours after symptom onset.
1-3 Mechanical thrombectomy (MT) was limited to basilar artery occlusions and situations in which IVT was contraindicated.
4-8 However, since December 2014, several clinical trials
9-14 have acknowledged the superiority of bridging therapy, which consists of IVT within 4.5 hours followed by MT within 6 hours of symptom onset, over IVT alone in AIS with a large vessel occlusion (LVO) of the anterior circulation.